Models for Strategic Success in Medtech
During the next decade, the traditional medical technology business model is likely to experience the same type of adjustment as has occurred in pharmaceuticals. This change could lead to current market leaders getting displaced by companies that lead the creation of new business models that are consistent with future market requirements for differentiated customer value provision.
There will be several key strategic process and capability building blocks that future winning customer value propositions and profit realization models with build around. These include:
- The innovation model
- The commercial model
- Building new capabilities
- Significant reduction in the cost structure
- Global with emerging market focus
- Business consolidation and leadership
This video presentation explores how medical device companies and the industry itself can increase the likelihood of successfully evolving to meet future challenges and maintaining a competitive profile by adapting business models to a changing environment.
About the Presenter
James Gilbert is a strategy lecturer at Babson College. He also is currently a senior advisor at Welsh, Carson, Anderson, and Stowe private equity focused on healthcare, and a board member at Charity Partners. Gilbert previously served in several senior leadership roles at Boston Scientific including roles as Corporate Executive Vice President of Strategy and Group President, Cardiovascular. From 1981-2004, Gilbert was a Partner and Director at Bain & Company with responsibility for the global healthcare practice.